BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 21361405)

  • 1. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A note on the use of influenza vaccination strategies when supply is limited.
    Lee S; Morales R; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the strategies for age specific vaccination scheduling during influenza pandemic outbreaks.
    Knipl DH; Röst G
    Math Biosci Eng; 2011 Jan; 8(1):123-39. PubMed ID: 21361404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic novel 2009 H1N1 influenza: what have we learned?
    LaRussa P
    Semin Respir Crit Care Med; 2011 Aug; 32(4):393-9. PubMed ID: 21858744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vaccination strategies during pandemic outbreaks.
    Bowman CS; Arino J; Moghadas SM
    Math Biosci Eng; 2011 Jan; 8(1):113-22. PubMed ID: 21361403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic.
    Sharomi O; Podder CN; Gumel AB; Mahmud SM; Rubinstein E
    Bull Math Biol; 2011 Mar; 73(3):515-48. PubMed ID: 20379852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
    Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple outbreaks for the same pandemic: Local transportation and social distancing explain the different "waves" of A-H1N1pdm cases observed in México during 2009.
    Herrera-Valdez MA; Cruz-Aponte M; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):21-48. PubMed ID: 21361398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why were Turks unwilling to accept the A/H1N1 influenza-pandemic vaccination? People's beliefs and perceptions about the swine flu outbreak and vaccine in the later stage of the epidemic.
    Gaygısız Ü; Gaygısız E; Özkan T; Lajunen T
    Vaccine; 2010 Dec; 29(2):329-33. PubMed ID: 20979988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic 2009-2010 influenza vaccine: six lessons learned and the way forward (Allegro not Adagio).
    Poland GA
    Vaccine; 2011 Jan; 29(4):613-4. PubMed ID: 21193121
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.
    Sym D; Patel PN; El-Chaar GM
    Ann Pharmacother; 2009 Dec; 43(12):2001-11. PubMed ID: 19920156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection.
    Nelson CA; France EK; Shetterly SM; Glanz JM
    Pediatr Infect Dis J; 2011 Jul; 30(7):562-5. PubMed ID: 21248657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.